Enliven Therapeutics, Inc (ELVN) Tops Q3 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts ELVN Hot Sheet
Join SI Premium – FREE
Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q3 EPS of ($0.32), $0.18 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Check Point Software Technology (CHKP) Reports In-Line Q3 EPS
- Citi cuts Arthur J. Gallagher rating to Neutral, lifts target
- Wendy's (WEN) spreader of 2K contracts of December 7 and January 8 calls
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
